ClinConnect ClinConnect Logo
Search / Trial NCT05930483

Remotely Delivered, Culturally Tailored Weight Loss Interventions Among Latina Breast Cancer Survivors

Launched by FRED HUTCHINSON CANCER CENTER · Jun 26, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a special weight loss program designed for Latina women who have survived breast cancer. The program is delivered online and is tailored specifically to meet the needs and culture of Latina survivors. Since many Latina survivors struggle with being overweight or obese, which can affect their health after cancer, this trial aims to provide the support they need to lose weight and improve their health outcomes.

To participate, you must be a biologically female, Hispanic or Latina, at least 18 years old, and have been diagnosed with stage I to III breast cancer within the last five years. You should also have a body mass index (BMI) of 30 or higher, which means you are considered overweight. Participants need to have access to a phone and the internet for the online program, as well as live in an area where grocery delivery is available. Throughout the study, you will receive support for a full year to help you with weight loss and maintaining a healthier lifestyle.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Biologically female
  • Age \>= 18 years
  • Self-identifies Hispanic/Latina
  • Fluent in Spanish and/or English
  • Previously diagnosis of stage I-III BC within the past 5 years
  • No evidence of recurrent or metastatic disease
  • \> 60 days post treatment (current endocrine therapy allowed)
  • Body mass index (BMI) \>= 30 kg/m\^2 initially assessed via self-reported height and weight and confirmed prior to randomization via a tape measure and WiFi-enabled scale
  • Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1
  • Physician written clearance for participation in a 12 month weight loss program
  • Willingness to participate in all study activities
  • Access to phone for study contacts
  • Access to internet and smartphone, tablet, or computer to participate in the online program and to be able to sync study WiFi devices
  • Lives within grocery delivery range for online delivery service
  • Successful completion of at-home baseline assessments prior to randomization
  • Exclusion Criteria:
  • Body mass index (BMI) \< 30 kg/m\^2
  • Active smoker
  • Diabetic with use of insulin or other hypoglycemic medication
  • Major comorbidities or physical limitations that would preclude from healthy weight loss, reducing energy intake or engaging in PA
  • Pregnant, breastfeeding, or planning to become pregnant during the study period
  • Use of exogenous hormones for gender affirmation

About Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center is a leading nonprofit research institution dedicated to the pursuit of innovative cancer treatments and prevention strategies. Established in Seattle, Washington, the center is renowned for its pioneering work in hematopoietic cell transplantation and its commitment to advancing cancer research through collaborative clinical trials. By integrating cutting-edge science with compassionate patient care, Fred Hutchinson Cancer Center aims to improve outcomes for patients while fostering a multidisciplinary approach to tackling complex cancer challenges. With a strong emphasis on translating research findings into clinical applications, the center is at the forefront of developing novel therapies that offer hope to patients worldwide.

Locations

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Heather Greenlee

Principal Investigator

Fred Hutch/University of Washington Cancer Consortium

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported